The Value of MRI and Radiomics for the Diagnostic Evaluation of Thyroid-Associated Ophthalmopathy

被引:0
作者
Zhou, Weiyi [1 ]
Song, Yan [1 ]
Shi, Jufeng [1 ]
Li, Tuo [1 ]
机构
[1] Naval Med Univ, Dept Endocrinol, Affiliated Hosp 2, Shanghai 200003, Peoples R China
基金
中国国家自然科学基金;
关键词
thyroid-associated ophthalmopathy; TAO; magnetic resonance imaging; MRI; radiomics; diagnosis; GRAVES OPHTHALMOPATHY; OPTIC NEUROPATHY; MAGNETIZATION-TRANSFER; EXTRAOCULAR-MUSCLES; CLINICAL ACTIVITY; SIGNAL INTENSITY; DISEASE-ACTIVITY; LACRIMAL GLAND; ORBITOPATHY; THERAPY;
D O I
10.3390/diagnostics15030388
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thyroid-associated ophthalmopathy (TAO) is a vision-threatening autoimmune disease that involves the extraocular muscles (EOMs) and periorbital fat. Typical signs of TAO include eyelid recession, proptosis, diplopia, and decreased visual acuity. As a self-limited disease, there is major bipolarity in clinical outcomes in TAO population. The early diagnosis and prediction of these refractory and relapsed patients is essential. Unfortunately, commonly used tools such as CAS/NOSPECTS, are based on clinical symptoms and signs alone, have significant limitations. Some imaging techniques or examinations, such as magnetic resonance imaging (MRI), can be very effective in assisting TAO assessment, from exhaustive whiteboard notes to optimized patient outcomes. Being one of the most commonly used and accurate objective examinations for TAO assessment, MRI boosts no ionizing radiation, high soft tissue contrast, better reflection of tissue water content, and the ability to quantify multiple parameters. In addition, novel MR sequences are becoming increasingly more familiar in TAO and other areas of clinical and scientific research. Moreover, radiomics, a method involving the extraction of a large number of features from medical images through algorithms, is a more recent approach used in the analysis and characterization of TAO data. Thus, this review aims to summarize and compare the value of routine and novel functional MRI sequences and radiomics prediction models in the diagnosis and evaluation of TAO.
引用
收藏
页数:13
相关论文
共 70 条
[1]  
Li Z., Luo Y., Feng X., Zhang Q., Zhong Q., Weng C., Chen Z., Shen J., Application of Multiparameter Quantitative Magnetic Resonance Imaging in the Evaluation of Graves’ Ophthalmopathy, J. Magn. Reson. Imaging, 58, pp. 1279-1289, (2023)
[2]  
Li R., Li J., Wang Z., Quantitative assessment of the intraorbital segment of the optic nerve in patients with thyroid orbitopathy using diffusion tensor imaging, Acta Radiol, 64, pp. 725-731, (2023)
[3]  
Wong N.T.Y., Yuen K.F.K., Aljufairi F.M.A.A., Lai K.K.H., Hu Z., Chan K.K.W., Tham C.C.Y., Pang C.P., Chong K.K.L., Magnetic resonance imaging parameters on lacrimal gland in thyroid eye disease: A systematic review and meta-analysis, BMC Ophthalmol, 23, (2023)
[4]  
Hu H., Chen L., Zhang J., Chen W., Chen H., Liu H., Shi H., Wu F., Xu X., T2-Weighted MR Imaging-Derived Radiomics for Pretreatment Determination of Therapeutic Response to Glucocorticoid in Patients with Thyroid-Associated Ophthalmopathy: Comparison with Semiquantitative Evaluation, J. Magn. Reson. Imaging, 56, pp. 862-872, (2022)
[5]  
Wu D., Zhu H., Hong S., Li B., Zou M., Ma X., Zhao X., Wan P., Yang Z., Li Y., Et al., Utility of multi-parametric quantitative magnetic resonance imaging of the lacrimal gland for diagnosing and staging Graves’ ophthalmopathy, Eur. J. Radiol, 141, (2021)
[6]  
Jiang M., Song X., Zhang H., Tao X., Yang G., Wang Y., Liu Y., Zhou H., Sun J., Li Y., The combination of T2-mapping value of lacrimal gland and clinical indicators can improve the stage prediction of Graves’ ophthalmopathy compared to clinical activity scores, Endocrine, 78, pp. 321-328, (2022)
[7]  
Liu X., Su Y., Jiang M., Fang S., Huang Y., Li Y., Zhong S., Wang Y., Zhang S., Wu Y., Et al., Application of Magnetic Resonance Imaging in the Evaluation of Disease Activity in Graves’ Ophthalmopathy, Endocr. Pract, 27, pp. 198-205, (2021)
[8]  
Sorace A.G., Elkassem A.A., Galgano S.J., Lapi S.E., Larimer B.M., Partridge S.C., Quarles C.C., Reeves K., Napier T.S., Song P.N., Et al., Imaging for Response Assessment in Cancer Clinical Trials, Semin. Nucl. Med, 50, pp. 488-504, (2020)
[9]  
Liu P., Luo B., Zhai L.-H., Wu H.-Y., Wang Q.-X., Yuan G., Jiang G.-H., Chen L., Zhang J., Multi-Parametric Diffusion Tensor Imaging of The Optic Nerve for Detection of Dysthyroid Optic Neuropathy in Patients with Thyroid-Associated Ophthalmopathy, Front. Endocrinol, 13, (2022)
[10]  
Basser P.J., Pierpaoli C., Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI, J. Magn. Reson. B, 111, pp. 209-219, (1996)